Neural Markers of Early Treatment Response During Antidepressant Treatment in Major Depressive Disorder

被引：0
|
作者：
Ramasubbu, Rajamannar [1 ]
Goodyear, Bradley [1 ]
Gaxiola, Ismael [1 ]
MacQueen, Glenda [1 ]
机构：
[1] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
来源：
BIOLOGICAL PSYCHIATRY | 2010年 / 67卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
505
引用
收藏
页码：145S / 145S
页数：1
相关论文
共 50 条
  • [31] An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study
    Spronk, D.
    Arns, M.
    Barnett, K. J.
    Cooper, N. J.
    Gordon, E.
    JOURNAL OF AFFECTIVE DISORDERS, 2011, 128 (1-2) : 41 - 48
  • [32] Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
    Rashidian, Houman
    Subramaniapillai, Mehala
    Park, Caroline
    Lipsitz, Orly
    Zuckerman, Hannah
    Cao, Bing
    Lee, Yena
    Gill, Hartej
    Rodrigues, Roger Nelson
    Di Vincenzo, Joshua D.
    Iacobucci, Michelle
    Jaberi, Saja
    Rosenblat, Joshua D.
    McIntyre, Roger S.
    Mansur, Rodrigo B.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (03) : 313 - 317
  • [33] Resting State Amygdala Functional Connectivity and Antidepressant Treatment Response in Major Depressive Disorder
    Okada, Go
    Okamoto, Yasumasa
    Takamura, Masahiro
    Toki, Shigeru
    Yamamoto, Tetsuya
    Yamawaki, Shigeto
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S241 - S241
  • [34] A role for genetics in the outcome of antidepressant treatment for major depressive disorder
    Semaka, A.
    CLINICAL GENETICS, 2006, 70 (02) : 110 - U1
  • [35] Antidepressant Medication Prescribing Practices for Treatment of Major Depressive Disorder
    Trevino, Lara A.
    Ruble, Matthew W.
    Trevino, Kenneth
    Weinstein, Lawrence M.
    Gresky, Dana P.
    PSYCHIATRIC SERVICES, 2017, 68 (02) : 199 - 202
  • [36] Sexual dysfunction associated with major depressive disorder and antidepressant treatment
    Clayton, Anita H.
    El Haddad, Saria
    Iluonakhamhe, Josepha-Pearl
    Martinez, Caridad Ponce
    Schuck, Alexandra Elizabeth
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (10) : 1361 - 1374
  • [37] Choosing a second generation antidepressant for treatment of major depressive disorder
    Lester, Helen
    Gilbody, Simon
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [38] Antidepressant treatment in patients with fibromyalgia and comorbid major depressive disorder
    Aguglia, E.
    Aguglia, A.
    Amato, C.
    Petralia, A.
    Ullo, A.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2009, 66 (06) : 547 - 547
  • [39] Serum BDNF in OCD and major depressive disorder patients before and during antidepressant treatment
    Chiavetto, L. Bocchio
    Rosso, G.
    Zanardini, R.
    Chiarle, A.
    Bogetto, F.
    Gennarelli, M.
    Maina, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S541 - S541
  • [40] Surrogate markers of treatment outcome in major depressive disorder
    Papakostas, George I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (06): : 841 - 854
12345